- Home
- FRPT vs CORT Comparison
FRPT vs CORT Comparison
Compare FRPT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPT
- CORT
- Stock Information
- Founded
- FRPT 2004
- CORT 1998
- Country
- FRPT United States
- CORT United States
- Employees
- FRPT N/A
- CORT N/A
- Industry
- FRPT Packaged Foods
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- FRPT Consumer Staples
- CORT Health Care
- Exchange
- FRPT Nasdaq
- CORT Nasdaq
- Market Cap
- FRPT 6.5B
- CORT 5.9B
- IPO Year
- FRPT 2014
- CORT N/A
- Fundamental
- Price
- FRPT $145.17
- CORT $52.17
- Analyst Decision
- FRPT Strong Buy
- CORT Strong Buy
- Analyst Count
- FRPT 15
- CORT 4
- Target Price
- FRPT $160.13
- CORT $75.25
- AVG Volume (30 Days)
- FRPT 442.5K
- CORT 848.2K
- Earning Date
- FRPT 11-04-2024
- CORT 02-13-2025
- Dividend Yield
- FRPT N/A
- CORT N/A
- EPS Growth
- FRPT N/A
- CORT 57.97
- EPS
- FRPT 0.88
- CORT 1.26
- Revenue
- FRPT $927,890,000.00
- CORT $628,555,000.00
- Revenue This Year
- FRPT $29.89
- CORT $46.29
- Revenue Next Year
- FRPT $24.58
- CORT $17.09
- P/E Ratio
- FRPT $164.10
- CORT $41.38
- Revenue Growth
- FRPT 29.36
- CORT 39.67
- 52 Week Low
- FRPT $82.16
- CORT $20.84
- 52 Week High
- FRPT $160.91
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- FRPT 44.58
- CORT 37.38
- Support Level
- FRPT $139.43
- CORT $49.51
- Resistance Level
- FRPT $143.90
- CORT $60.90
- Average True Range (ATR)
- FRPT 3.67
- CORT 2.60
- MACD
- FRPT -0.91
- CORT -1.16
- Stochastic Oscillator
- FRPT 34.91
- CORT 13.83
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. The former two store types accounted for 89% of 2023 sales, with grocery stores representing the primary driver of footprint growth. Freshpet primarily targets dogs (92% of sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 96% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.